Clinical Trials Browser

Phase 2 × Recruiting × Anxiety Disorders × Clear all

NCT07002034 2026-04-22

RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses

Phase 2 Recruiting

Adjustment Disorders, Amyotrophic Lateral Sclerosis, Anxiety Disorders, Depression, Multiple Sclerosis, Neoplasms, Idiopathic Pulmonary Fibrosis

NCT04513444 2026-04-20

HYPNOMUSE

Phase 2 Recruiting

Anxiety Disorders

NCT07336238 2026-04-17

Group Retreat Psilocybin Therapy for the Treatment of Anxiety and Depression in Patients With Metastatic Solid Tumors or Incurable Hematologic Malignancies

Phase 2 Recruiting

Anxiety Disorders, Depression, Neoplasm Metastasis

NCT06200155 2026-04-16

Psilocybin-Assisted Psychotherapy in Patients With Advanced Cancer on Maintenance Therapy

Phase 2 Recruiting

Anxiety Disorders, Depression

NCT06801041 2026-04-16

TRIPS - Treatment to Improve Depression and/or Anxiety Using Psilocybin-assisted Psychotherapy in Cancer Survivors

Phase 2 Recruiting

Anxiety Disorders, Depression, Neoplasms

NCT07174947 2026-03-24

SSRI Antidepressant Fluoxetine Improving Immunotherapy Efficacy in Advanced Hepatobiliary Malignancy Patients With Depression and Anxiety

Phase 2 Recruiting

Anxiety Disorders

NCT06266611 2025-08-01

ARCTiC

Phase 2 Recruiting

Anxiety Disorders, Depression, Pain

NCT06081348 2025-07-16

CALM

Phase 2 Recruiting

Autism Spectrum Disorder, Anxiety Disorders, Attention Deficit Disorder with Hyperactivity, Autistic Disorder, DiGeorge Syndrome, Fragile X Syndrome, Tourette Syndrome, Tic Disorders, Tuberous Sclerosis, 22q11 Deletion Syndrome, Neurodevelopmental Disorders